Switch to ADA Accessible Theme
Close Menu
National Disability Attorney 877-655-2667
  • facebook
  • twitter
  • linkedin
Steve@BarzLaw.com
Disability Lawyer > Blog > SSD Eligibility > Does a Cancer Diagnosis Make Me Eligible for the Compassionate Allowances Program?

Does a Cancer Diagnosis Make Me Eligible for the Compassionate Allowances Program?

CancerDiag

If you have received a cancer diagnosis, are you eligible to have your SSDI application expedited under the Compassionate Allowances (CAL) program? It depends. There are a wide range of types of cancer that are listed in the CAL program’s list, but it will depend on the type of cancer and, in many cases, the staging of the cancer. We can explain in more detail below, and we can speak with you today if you have questions about SSDI eligibility or your eligibility for the CAL program.

Cancer and Compassionate Allowances Program Conditions

The CAL list includes the following types of cancer with some additional required qualifications:

  • Acute leukemia;
  • Adrenal cancer with distant metastases or inoperable, unresectable, or recurrent;
  • Adult non-Hodgkin lymphoma;
  • Alveolar soft part sarcoma;
  • Anaplastic adrenal cancer in an adult with distant metastases or inoperable, unresectable, or recurrent;
  • Anaplastic thyroid cancer;
  • Angiosarcoma;
  • Astrocytoma grade III or IV;
  • Atypical teratoid/rhaboid tumor;
  • Bilateral retinoblastoma;
  • Bladder cancer with distant metastases or inoperable, unresectable, or recurrent;
  • Blastic plasmacytoid dendritic cell neoplasm;
  • Breast cancer with distant mestastases or recurrent;
  • Carcinoma of unknown primary site;
  • Child lymphoblastic lymphoma;
  • Child lymphoma;
  • Child medulloblastoma;
  • Child neuroblastoma with distant mestastases or recurrent;
  • Cholangiocarcinoma;
  • Chondrosarcoma with multimodal therapy;
  • Choroid plexus carcinoma;
  • Chromic myelogenous leukemia (CML) blast phase;
  • CIC-rearranged sarcoma;
  • Desmoplastic mesothelioma;
  • Desmoplastic small round cell tumors;
  • Endometrial stromal sarcoma;
  • Ependymoblastoma;
  • Esophageal cancer;
  • Esthesioneuroblastoma;
  • Ewing sarcoma;
  • Fibromellar cancer;
  • Follicular dendritic cell carcinoma with mestastases or recurrent;
  • Gallbladder cancer;
  • Glioblastoma multiforme;
  • Glioma grade III and Grade IV;
  • Head and neck cancers with distant metastases or inoperable, unresectable, or recurrent;
  • Hepatoblastoma;
  • Hepatocellular carcinoma;
  • Histiocytic malignancies;
  • Inflammatory breast cancer;
  • Intracranial hemangiopericytoma;
  • Kidney cancer that is inoperable or unresectable;
  • Large intestine cancer with distant metastases or inoperable, unresectable, or recurrent;
  • Leiomyosarcoma;
  • Liposarcoma that is metastatic or recurrent;
  • Lymphomatoid granulomatosis grade III;
  • Malignant brainstem gliomas;
  • Malignant ectomesenchymoma;
  • Malignant gastrointestinal stromal tumor;
  • Malignant germ cell tumor;
  • Malignant renal rhaboid tumor;
  • Mantle cell lymphoma (MCL);
  • Merkel cell carcinoma with metastasis;
  • Metastatic endometrial adenocarcinoma;
  • Mucosal malignant melanoma;
  • Myelodysplastic syndrome with excess blasts;
  • Non-small cell lung cancer;
  • NUT carcinoma;
  • Oligodendroglioma brain cancer grade III;
  • Osteosarcoma;
  • Ovarian cancer with distant metastases or inoperable or unresectable;
  • Pancreatic cancer;
  • Pericardial mesothelioma;
  • Peripheral nerve cancer that is metastatic or recurrent;
  • Peritoneal mesothelioma;
  • Pineoblastoma;
  • Plasmatic lymphoma;
  • Pleural mesothelioma;
  • Primary central nervous system lymphoma;
  • Primal omental cancer;
  • Primary peritoneal cancer;
  • Refractory Hodgkin Lymphoma;
  • Renal medullary carcinoma;
  • Rhabdomyosarcoma;
  • Salivary cancers;
  • Sarcomatoid carcinoma of the lung stage II, III, or IV;
  • Sarcomatoid mesothelioma;
  • Secondary adenocarcinoma of the brain;
  • Sinonasal cancer;
  • Skin malignant melanoma with metastases;
  • Small cell cancer of the female genital tract;
  • Small cell cancer of the large intestine;
  • Small cell cancer of the ovary;
  • Small cell cancer of the prostate;
  • Small cell cancer of the thymus;
  • Small cell lung cancer;
  • Small intestine cancer with distant metastases or inoperable, unresectable, or recurrent;
  • Soft tissue carcinoma with distant mestastases or recurrent;
  • Spinal nerve root cancer that is metastatic or recurrent;
  • Stomach cancer with distant metastases or inoperable, unresectable, or recurrent;
  • Thymic carcinoma;
  • Ureter cancer with distant metastases or inoperable, unresectable, or recurrent; and
  • WHO grade III meningiomas.

It is possible that the list may be updated or expanded at a later date.

Contact Our National SSD Eligibility Attorney for Help Seeking Faster Benefits through the Compassionate Allowances Program

Do you have questions about your eligibility for the expedited CAL program for SSD benefits? The experienced national SSD eligibility lawyers at the Law Offices of Stephen Barszcz can speak with you today and can begin working with you on your application.

Source:

ssa.gov/compassionateallowances/

Facebook Twitter LinkedIn

Free Case
Evaluation

We want to hear from you. Give us a call or fill out our quick online contact form to schedule your free consultation with our attorney.

© 2019 - 2026 Law Offices of Stephen Barszcz. All rights reserved.
This law firm website and legal marketing are managed by MileMark Media.